NCT04071600View on ClinicalTrials.gov

Intranasal Neuropeptide Y in Clinical Trial in Level Two Trauma Patients for PTSD and Acute Stress Disorder

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

October 31, 2022

Study Completion Date

November 1, 2022

Conditions
Stress Disorders, Post-TraumaticStress Disorders, Traumatic, Acute
Interventions
DRUG

Neuropeptide Y

Intranasal

OTHER

Placebo

intranasal

Trial Locations (2)

10595

New York Medical College, Valhalla

Westchester Medical Center, Valhalla

Sponsors
All Listed Sponsors
collaborator

Westchester Medical Center

OTHER

collaborator

U.S. Army Medical Research and Development Command

FED

lead

New York Medical College

OTHER